Home > Boards > US Listed > Medical - Drugs >

Palatin Technologies Inc. (PTN)

PTN RSS Feed 		Add PTN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/22/2020 12:05:31 PM - Followers: 182 - Board type: Free - Posts Today: 1

http://www.palatin.com/

http://finance.yahoo.com/q/ks?s=PTN+Key+Statistics

Palatin Technologies, Inc., a biopharmaceutical company, develops peptide, peptide mimetic, and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems in the United States. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist for the treatment of sexual dysfunction, targeting female sexual dysfunction and erectile dysfunction in patients non-responsive to current therapies; peptide and small molecule melanocortin receptor agonists for treatment of female sexual dysfunction, erectile dysfunction, and other indications; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist for the treatment of acute exacerbations of asthma and heart failure. The company has research collaboration and license agreement with AstraZeneca AB to commercialize compounds that target melanocortin receptors for the treatment of obesity, diabetes, and related metabolic syndrome. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.



PTN
Current Price
Volume:
Bid Ask Day's Range
PTN Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PTN News: Palatin Provides Corporate Update and 2020 Calendar Outlook 01/21/2020 07:30:00 AM
PTN News: Current Report Filing (8-k) 11/13/2019 08:47:01 AM
PTN News: Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2020 Results and Provides Corporate Update 11/13/2019 07:30:00 AM
PTN News: Quarterly Report (10-q) 11/12/2019 04:58:22 PM
PTN News: Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on Novembe... 11/07/2019 07:30:00 AM
PostSubject
#3399   IT IS READY TO MOVE TO THE UPSIDE. johnb214 01/22/20 12:05:30 PM
#3398   PTN: FLATLINED, LOCKED AND LOADED. STANDBY FOR johnb214 01/21/20 01:34:09 PM
#3397   "2019 was pivotal for Palatin - we had runcaly 01/21/20 08:03:32 AM
#3396   What does the divestment of Vyleesi by AMAG Mejahfo 01/20/20 11:17:35 PM
#3395   PTN: IF THEY ARE PRESENTING AT THE johnb214 01/14/20 02:28:02 PM
#3394   * * $PTN Video Chart 01-13-2020 * * ClayTrader 01/13/20 04:56:49 PM
#3393   * * $PTN Video Chart 01-10-2020 * * ClayTrader 01/10/20 04:45:34 PM
#3392   Bit of a head-scratcher why the stock price Masta SkillZ 01/10/20 01:45:37 PM
#3391   We know they are in active negotiations with Ditryin 12/30/19 11:55:59 PM
#3390   Any thoughts on how the company will perform DesireToLearn 12/28/19 12:20:22 AM
#3389   Thanks bigbut. I use bremelanotide myself and experience BesaoT35 12/22/19 01:23:05 PM
#3388   Your facts are not correct Much of the bigbut 12/22/19 12:47:17 AM
#3387   I think that Vyleesi is more effective in BesaoT35 12/19/19 04:20:49 PM
#3386   Palatin Technologies, Inc. CONTACT THEM ON ALL VENUES johnb214 12/18/19 11:04:07 AM
#3385   You must be new Bankroll423 12/07/19 09:14:43 PM
#3384   Manipulate it down then takeover costs less. Monroe1 12/03/19 01:58:32 PM
#3383   PTN has $3.5 million in revenue per year BesaoT35 12/01/19 02:19:57 PM
#3382   Thank you for the reply. chantillylive 11/22/19 04:37:43 PM
#3381   I think you’ll have time at around these Investing2day 11/22/19 04:25:35 PM
#3380   Can't decide whether to add to my position chantillylive 11/22/19 03:37:47 PM
#3379   No, that offering was done prior to FDA Ditryin 11/22/19 12:38:18 PM
#3378   One example is when the FDA approved Vyleesi BesaoT35 11/22/19 10:12:33 AM
#3377   What examples do you have of mgt screwing shareholders? DesireToLearn 11/21/19 07:33:09 PM
#3376   Wow, there is a spread between 0,7979 to runcaly 11/20/19 12:59:22 PM
#3375   Return on capital is 52%. Return on equity BesaoT35 11/20/19 06:26:01 AM
#3374   Love the fact they have zero debt and Investing2day 11/19/19 09:23:21 AM
#3373   Investing2day... Thank you for your response. chantillylive 11/19/19 08:26:22 AM
#3372   Everyone needs to email PTN and tell them johnb214 11/18/19 02:37:04 PM
#3371   I think anything around these prices are truly Investing2day 11/18/19 02:19:55 PM
#3370   All... is anyone adding at this PPS chantillylive 11/15/19 01:21:16 PM
#3369   A lot of buyers yesterday ... runcaly 11/13/19 06:31:06 AM
#3368   Is your love life looking better? blue_skies 11/02/19 06:42:38 PM
#3366   I just had a video appointment with a bleu22 11/01/19 08:34:09 AM
#3365   PTN If the prescription count keeps increasing as johnb214 10/31/19 03:06:51 PM
#3364   PTN Watch AMAG for a breakout and buyout johnb214 10/28/19 12:53:16 AM
#3363   Once you’re a beneficial owner you have to bigbut 10/11/19 05:30:54 PM
#3362   * * $PTN Video Chart 10-09-2019 * * ClayTrader 10/09/19 05:35:02 PM
#3361   PTN/AMAG AMAG This is the first part of a johnb214 10/08/19 02:23:02 PM
#3360   I'm not sure, but I can say the DesireToLearn 10/02/19 09:06:20 PM
#3359   Could Caligan Partners be actively shorting our stock BesaoT35 10/01/19 03:44:14 PM
#3358   great post. Thanks Monroe1 09/30/19 03:43:50 PM
#3357   Thanks whytestocks. That was such a positive BesaoT35 09/29/19 03:27:47 PM
#3356   News: $PTN Palatin Technologies (PTN) Q4 2019 Earnings whytestocks 09/27/19 01:50:24 PM
#3355   * * $PTN Video Chart 09-24-2019 * * ClayTrader 09/24/19 04:13:27 PM
#3354   Caligan Partners Hedge Fund seems to have an BesaoT35 09/23/19 02:14:16 PM
#3353   I was reading the statement of one of johnb214 09/22/19 05:13:46 PM
#3352   Totally agree John. With the approval on their timetravelerdos 09/15/19 08:10:17 PM
#3351   There are two significant numbers that are important johnb214 09/15/19 12:11:37 PM
#3350   Palatin Technologies Q4 EPS $0.23 Up From $0.06 timetravelerdos 09/14/19 12:56:07 PM
#3349   6456 nyse 1.06 38,399 1.06 1.08 20:00:00 38,399 1,401,092 859,059 491,767 johnb214 09/14/19 11:15:00 AM
PostSubject
© 2020 InvestorsHub.com, Inc.